Detalles de la búsqueda
1.
AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders.
Gastroenterology
; 166(1): 59-85, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38128971
2.
Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease.
Gastroenterology
; 2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38490347
3.
Impact of Treatment Response on Risk of Serious Infections in Patients With Crohn's Disease: Secondary Analysis of the PYRAMID Registry.
Clin Gastroenterol Hepatol
; 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38216022
4.
Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysis.
Clin Gastroenterol Hepatol
; 22(1): 22-33.e6, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37716619
5.
Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn's Disease (CD).
Dig Dis Sci
; 69(1): 235-245, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38015321
6.
Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis.
Gut
; 72(11): 2068-2080, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37080587
7.
Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
Clin Gastroenterol Hepatol
; 21(1): 173-181.e5, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644340
8.
Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study.
Clin Gastroenterol Hepatol
; 21(9): 2359-2369.e5, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36343846
9.
Azathioprine Withdrawal Is Cost-Effective in Patients with Crohn's Disease in Remission on Infliximab and Azathioprine.
Dig Dis Sci
; 68(2): 404-413, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36512266
10.
Interactive Inflammatory Bowel Disease Biologics Decision Aid Does Not Improve Patient Outcomes Over Static Education: Results From a Randomized Trial.
Am J Gastroenterol
; 117(9): 1508-1518, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35973146
11.
Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
Am J Gastroenterol
; 117(10): 1639-1647, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35973139
12.
Magnitude of Preoperative C-Reactive Protein Elevation Is Associated With De Novo Crohn's Disease After Ileal Pouch-Anal Anastomosis in Patients With Severe Colitis.
Dis Colon Rectum
; 65(3): 399-405, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34657077
13.
Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology.
Dig Dis Sci
; 67(10): 4687-4694, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35006492
14.
Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium.
Clin Gastroenterol Hepatol
; 19(10): 2207-2209.e3, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33068786
15.
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 19(8): 1592-1601.e3, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32629130
16.
Preoperative Serum Vedolizumab Levels Do Not Impact Postoperative Outcomes in Inflammatory Bowel Disease.
Dis Colon Rectum
; 64(10): 1259-1266, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34516445
17.
Antitumour necrosis factor therapy is associated with de novo Crohn's disease after ileal pouch-anal anastomosis.
Colorectal Dis
; 23(9): 2416-2424, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34157179
18.
Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis.
Dig Dis Sci
; 66(1): 199-205, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32170473
19.
Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease.
Gastroenterology
; 161(6): 2041-2043.e1, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34391771
20.
Seizures as a Potential Complication of Treatment With Simeprevir and Sofosbuvir.
Am J Ther
; 23(2): e570-1, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-25549078